Shine Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 3.38 Cr
- Company Age 30 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.68 M
- Satisfied Charges ₹ 9.30 Cr
- Revenue Growth 18.64%
- Profit Growth -27.72%
- Ebitda -25.92%
- Net Worth 17.78%
- Total Assets 11.07%
About Shine Pharmaceuticals
Shine Pharmaceuticals Limited (SPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 17 August 1994 and has a history of 30 years and six months. Its registered office is in Vadodara, Gujarat, India.
The Corporate was formerly known as Shine Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.38 Cr.
The company currently has active open charges totaling ₹0.68 M. The company has closed loans amounting to ₹9.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pradeep Agrawal, Hiranmay Saha, Aloka Saha, and Three other members serve as directors at the Company.
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231GJ1994PLC022787
- Company No.
022787
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Aug 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Shine Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samir Chakraborty  | Managing Director | 01-Apr-2005 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pradeep Agrawal | Whole-Time Director | 01-Jul-2003 | Current |
| Hiranmay Saha | Director | 30-May-1996 | Current |
| Aloka Saha | Whole-Time Director | 30-May-1996 | Current |
| Rangoli Gada | Director | 25-Mar-2023 | Current |
| Tejal Parikh | Director | 01-May-2024 | Current |
Financial Performance of Shine Pharmaceuticals.
Shine Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.64% increase. The company also saw a substantial fall in profitability, with a 27.72% decrease in profit. The company's net worth Soared by an impressive increase of 17.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shine Pharmaceuticals?
In 2023, Shine Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vital Care Pvt LtdPradeep Agrawal and Samir Chakraborty are mutual person
Bharat Petroleum Corporation LimitedPradeep Agrawal is a mutual person
Interpharm Biotech Private LimitedPradeep Agrawal and Samir Chakraborty are mutual person
Mew Electricals LimitedTejal Parikh is a mutual person
Bhoomi Medicaments LimitedPradeep Agrawal and Samir Chakraborty are mutual person
- Vadodara Smile Foundation
Pradeep Agrawal is a mutual person
Charges (Loans)
₹0.07 Cr
₹9.30 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jun 2019 | Axis Bank Limited | ₹0.68 M | Open |
| 24 Dec 2020 | Others | ₹2.00 Cr | Satisfied |
| 26 Sep 2019 | Others | ₹7.50 M | Satisfied |
| 03 Jan 2004 | Bank Of Baroda | ₹3.55 Cr | Satisfied |
| 05 Jul 2003 | Bank Of Baroda | ₹3.00 Cr | Satisfied |
How Many Employees Work at Shine Pharmaceuticals?
Shine Pharmaceuticals has a workforce of 721 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shine Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shine Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
